New drug shows promise for Hard-to-Treat blood cancer in early trial
NCT ID NCT04773522
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 22 times
Summary
This early-phase study tested a new drug called JNJ-64407564 in 15 Japanese patients with multiple myeloma that had come back or stopped responding to other treatments. The drug is a special antibody that helps the immune system attack cancer cells. The main goal was to check safety and find the right dose for future studies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Iwate Medical University Hospital
Shiwa-gun, 028-3695, Japan
-
Japanese Red Cross Medical Center
Shibuya City, 150-8935, Japan
-
Nagoya City University Hospital
Nagoya, 467 8602, Japan
-
National Cancer Center Hospital East
Kashiwa, 277 8577, Japan
-
National Hospital Organization Okayama Medical Center
Okayama, 701-1192, Japan
-
Shonan Kamakura General Hospital
Kamakura-shi, 247-8533, Japan
Conditions
Explore the condition pages connected to this study.